A new pessary

The Reia pessary is a collapsible pessary for pelvic organ prolapse. It collapses for insertion and removal and is designed for easy and comfortable maintenance by patients and practitioners. It can be used to treat all stages of prolapse.

Target release 2024 (pending FDA clearance).

HOW IT WORKS

Insertion

Lightly pinch the pessary to elongate it into a narrower shape

In Situ

Release the pessary to allow it to expand to its supportive state

Removal

Pull on the loop to re-elongate it

SIZING

3 Reia pessary sizes map to the most common sizes of current pessaries. A fitting kit will be available (right).

sizes cover 2” to 3.5”

Clinically proven pessary care

TRAIL RESULTS SUBMITTED TO FDA

The Reia pessary was used by 62 current pessary users for 3 months in a non-randomized prospective trial funded by the NIH to study effectiveness, safety, comfort, function & satisfaction.

  • Dartmouth-Hitchcock Clinic, Kris Strohbehn, MD

  • New York Medical College, Cara Grimes, MD

  • Beth-Israel Deaconess Medical Center, Peter Rosenblatt, MD

  • Women and Infants Hospital of Rhode Island, Charles Rardin, MD

  • University of Alabama at Birmingham, Holly Richter, MD

  • Main Line Health, Marc Toglia, MD

  • University of Texas Health, Gazala Siddiqui, MD

SITES & PRINCIPAL INVESTIGATORS

Compared to current pessaries, the Reia pessary resulted in:

  • Significant improvement in bother and impact of symptoms based on PFDI-20 and PFIQ-7 scores for subjects who completed the trial.

  • Significant reduction in pain during insertion and removal.

  • 13 subjects starting to self-manage.

  • Equally effective prolapse support (Ba & Bp) and symptom improvement based on PFDI-20 scores for all subjects treated.

RESULTS

UPCOMING RANDOMIZED CONTROLLED TRIAL

Reia is preparing for an RCT funded by the NIH to study self-management and quality of life impact between current pessaries and Reia’s devices. The Reia pessary will be trialed with the Reia applicator, which is being developed to aid with insertion.

The trial will be administered by the Foundation for Female Health Awareness and is on track to commence in 2024.

About Reia

Reia is a women owned business co-founded by urogynecologist Paul Hanissian, MD and led by Kaitlin Maier, CEO. The Reia pessary was developed with funding from the NIH.

We want to hear from you.

Do you have prolapse and have a product or educational resource you want to see?

Are you a practitioner interested in more information on Reia’s clinical trials & regulatory progress?